Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodica Stan

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Science (New York, N.Y.)|September 27, 2014
The borders I crossedRodica Stan
Current HIV/AIDS Reports|January 23, 2014
Practical considerations in gene therapy for HIV cureRodica Stan, John A Zaia
Hematology/Oncology Clinics of North America|June 10, 2006
DNA vaccines against cancerRodica Stan, Jedd D Wolchok, Adam D Cohen
Hematology (Amsterdam, Netherlands)|June 19, 2004
Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccinesDavid Z Chang, Whitney Lomazow, C Joy Somberg, et al.
Viruses|November 29, 2013
Development of hematopoietic stem cell based gene therapy for HIV-1 infection: considerations for proof of concept studies and translation to standard medical practiceDavid L DiGiusto, Rodica Stan, Amrita Krishnan, et al.
Innovations in Clinical Neuroscience|June 18, 2020
Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?David G Daniel, Alan Kott, Jay Saoud, et al.
Stem Cells Translational Medicine|November 7, 2017
Role of Nursing Competencies for Accelerating Clinical Trials in Stem Cell ClinicsMary Perrin, Teresa Kim, Rodica Stan, et al.
Advances in Immunology|May 30, 2006
Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligoHiroshi Uchi, Rodica Stan, Mary Jo Turk, et al.
Pigment Cell & Melanoma Research|March 27, 2013
The Ludwig institute for cancer research Melbourne melanoma cell line panelAndreas Behren, Matthew Anaka, Pu-Han Lo, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2015
Low-dose cyclophosphamide enhances antigen-specific CD4(+) T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanomaOliver Klein, Ian D Davis, Grant A McArthur, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Science (New York, N.Y.)|September 27, 2014
The borders I crossedRodica Stan
Current HIV/AIDS Reports|January 23, 2014
Practical considerations in gene therapy for HIV cureRodica Stan, John A Zaia
Hematology/Oncology Clinics of North America|June 10, 2006
DNA vaccines against cancerRodica Stan, Jedd D Wolchok, Adam D Cohen
Hematology (Amsterdam, Netherlands)|June 19, 2004
Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccinesDavid Z Chang, Whitney Lomazow, C Joy Somberg, et al.
Viruses|November 29, 2013
Development of hematopoietic stem cell based gene therapy for HIV-1 infection: considerations for proof of concept studies and translation to standard medical practiceDavid L DiGiusto, Rodica Stan, Amrita Krishnan, et al.
Innovations in Clinical Neuroscience|June 18, 2020
Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?David G Daniel, Alan Kott, Jay Saoud, et al.
Stem Cells Translational Medicine|November 7, 2017
Role of Nursing Competencies for Accelerating Clinical Trials in Stem Cell ClinicsMary Perrin, Teresa Kim, Rodica Stan, et al.
Advances in Immunology|May 30, 2006
Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligoHiroshi Uchi, Rodica Stan, Mary Jo Turk, et al.
Pigment Cell & Melanoma Research|March 27, 2013
The Ludwig institute for cancer research Melbourne melanoma cell line panelAndreas Behren, Matthew Anaka, Pu-Han Lo, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2015
Low-dose cyclophosphamide enhances antigen-specific CD4(+) T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanomaOliver Klein, Ian D Davis, Grant A McArthur, et al.
Pageof 2